Cannabinoids and cell fate

Pharmacology and Therapeutics

Volumn 95, Issue 2, 2002, Pages 175-184

  Guzmán, Manuel ^a   Sánchez, Cristina ^a   Galve Roperh, Ismael ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Cancer; Cannabinoids; Cell proliferation; Neuroprotection

Indexed keywords

CANNABINOID;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; DRUG MECHANISM; ENZYME ACTIVATION; GLIOBLASTOMA; GROWTH DISORDER; HUMAN; IMMUNOCOMPETENT CELL; INTOXICATION; ISCHEMIA; NERVE CELL; NEUROPROTECTION; OXIDATION; PRIORITY JOURNAL; RODENT;

EID: 0036669523     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00256-5     Document Type: Review

References (106)

1. Abood M.E., Rizvi G., Sallapudi N., McAllister S.D. Activation of the CB1 cannabinoid receptor protects cultured spinal neurons against neurotoxicity. Neurosci Lett. 309:2001;197-201.
2. Avgeropoulos N.G., Batchelor T.T. New treatment strategies for malignant gliomas. Oncologist. 4:1999;209-224.
3. Baker D., Pryce G., Croxford J.L., Brown P., Pertwee R.G., Huffman J.W., Layward L. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature. 404:2000;84-87.
4. Barañano D.E., Ferris C.D., Snyder S.H. Atypical neural messengers. Trends Neurosci. 24:2001;99-106.
5. Bayewitch M., Avidor-Reiss T., Levy R., Barg J., Mechoulam R., Vogel Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett. 375:1995;143-147.
6. 9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J Biol Chem. 271:1996;9902-9905.
7. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 277:1997;1094-1097.
8. 2 receptor responses by an anandamide transport inhibitor. J Neurosci. 20:2000;3401-3407.
9. Bisogno T., Katayama K., Melck D., Ueda N., De Petrocellis L., Yamamoto S., Di Marzo V. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells. Implications for cell proliferation and differentiation. Eur J Biochem. 254:1998;634-642.
10. Boger D.L., Sato H., Lerner A.E., Hedrick M.P., Fecik R.A., Miyauchi H., Wilkie G.D., Austin B.J., Patricelli M.P., Cravatt B.F. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for the degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci USA. 97:2000;5044-5049.
11. Bouaboula M., Bourrie B., Rinaldi-Carmona M., Shire D., Le Fur G., Casellas P. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem. 270:1995;13973-13980.
12. 1. Biochem J. 312:1995;637-641.
13. 2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem. 237:1996;704-711.
14. Cabral G.A., Dove Pettit D.A. Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol. 83:1998;116-123.
15. Carayon P., Marchand J., Dussossoy D., Derocq J.M., Jbilo O., Bord A., Bouaboula M., Galiègue S., Mondière P., Pénarier G., Le Fur G., Defrance T., Casellas P. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood. 92:1998;3605-3615.
16. 2+ current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol. 106:1992;231-232.
17. 9-tetrahydrocannabinol. J Neurosci. 18:1998;5322-5332.
18. 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fund Appl Toxicol. 30:1996;109-117.
19. Chen Y., Buck J. Cannabinoids protect cells from oxidative cell death: a receptor independent mechanism. J Pharmacol Exp Ther. 293:2000;807-812.
20. De Petrocellis L., Melck D., Palmisano A., Bisogno T., Laezza C., Bifulco M., Di Marzo V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA. 95:1998;8375-8380.
21. Derocq J.M., Segui M., Marchand J., Le Fur G., Casellas P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 369:1995;177-182.
22. Derocq J.M., Bouaboula M., Marchand J., Rinaldi-Carmona M., Ségui M., Casellas P. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett. 425:1998;419-425.
23. Derocq J.M., Jbilo O., Bouaboula M., Ségui M., Clère C., Casellas P. Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. J Biol Chem. 275:2000;15621-15628.
24. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
25. Di Marzo V., Melck D., Bisogno T., De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
26. Di Marzo V., Hill M.P., Bisogno T., Crossman A.R., Brotchie J.M. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J. 14:2000;1432-1438.
27. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22:1999;391-397.
28. Feigenbaum J.J., Bergmann F., Richmond S.A., Mechoulam R., Nadler V., Kloog Y., Sokolovsky M. Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc Natl Acad Sci USA. 86:1989;9584-9587.
29. Gallily R., Yamin A., Waksmann Y., Ovadia H., Weidenfeld J., Bar-Joseph A., Biegon A., Mechoulam R., Shohami E. Protection against septic shock and supression of tumor necrosis factor α and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid. J Pharmacol Exp Ther. 283:1997;918-924.
30. Galve-Roperh I., Sánchez C., Cortés M.L., Gómez del Pulgar T., Izquierdo M., Guzmán M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med. 6:2000;313-319.
31. Giuffrida A., Parsons L.H., Kerr T.M., Rodríguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci. 2:1999;358-363.
32. A receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience. 97:2000;505-519.
33. 1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J. 347:2000;369-373.
34. Goswami R., Dawson G. Does ceramide play a role in neural cell apoptosis? J Neurosci Res. 60:2000;141-149.
35. Grewal S.S., York R.D., Stork P.J.S. Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol. 9:1999;544-553.
36. Guzmán M., Blázquez C. Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab. 12:2001;169-173.
37. Guzmán M., Galve-Roperh I., Sánchez C. Ceramide, a new second messenger of cannabinoid action. Trends Pharmacol Sci. 22:2001;19-22.
38. Guzmán M., Sánchez C., Galve-Roperh I. Control of the cell survival/death decision by cannabinoids. J Mol Med. 78:2001;613-625.
39. Hampson A.J., Grimaldi M. Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity. Eur J Neurosci. 13:2001;1529-1536.
40. Hampson A.J., Bornheim L.M., Scanziani M., Yost C.S., Gray A.T., Hansen B.M., Leonoudakis D.J., Bickler P.E. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem. 70:1998;671-676.
41. 9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA. 95:1998;8268-8273.
42. Hansen H.H., Hansen S.H., Schousboe A., Hansen H.H. Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons. J Neurochem. 75:2000;861-869.
43. Hansen H.S., Lauritzen L., Moesgaard B., Strand A.M., Hansen H.H. Formation of N-acyl phosphatidylethanolamines and N-acyl ethanolamines. Proposed role in neurotoxicity. Biochem Pharmacol. 55:1998;719-725.
44. 2, a peripheral cannabinoid receptor. Proc Natl Acad Sci USA. 96:1999;14228-14233.
45. 1 cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. FEBS Lett. 459:1999;277-281.
46. Holland E.C. Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA. 97:2000;6242-6244.
47. Howlett A.C. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sci. 35:1984;1803-1810.
48. 2 receptor. Bioorg Med Chem. 7:1999;2905-2914.
49. Jacobsson S.O.P., Rongard E., Stridh M., Tiger G., Fowler C.J. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability. Biochem Pharmacol. 60:2000;1807-1813.
50. Jbilo O., Derocq J.M., Segui M., Le Fur G., Casellas P. Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60. FEBS Lett. 448:1999;273-277.
51. Kaminski N.E. Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors. J Neuroimmunol. 83:1998;124-132.
52. Klein T.W., Newton C., Friedman H. Cannabinoid receptors and immunity. Immunol Today. 19:1998;373-381.
53. Lee Y.S., Nam D.H., Kim J. Induction of apoptosis by capsaicin in A172 human glioblastoma cells. Cancer Lett. 161:2000;121-130.
54. 1 cannabinoid receptors in human vascular endothelial cells. Biochem J. 346:2000;835-840.
55. 9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol. 23:1989;73-81.
56. Maccarrone M., Lorenzon T., Bari M., Melino G., Finazzi-Agrò A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem. 275:2000;31938-31945.
57. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA. 89:1992;3825-3829.
58. Malfait A.M., Gallily R., Sumariwalla P.F., Malik A.S., Andreakos E., Mechoulam R., Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA. 97:2000;9561-9566.
59. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
60. Mehler M.F., Gokhan S. Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally-mediated cellular rheostat. Trends Neurosci. 23:2000;599-605.
61. Melck D., Rueda D., Galve-Roperh I., De Petrocellis L., Guzmán M., Di Marzo V. Involvement of the cAMP/protein kinase pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett. 463:1999;235-240.
62. Melck D., De Petrocellis L., Orlando P., Bisogno T., Laezza C., Bifulco M., Di Marzo V. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology. 141:2000;118-126.
63. Misner D.L., Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci. 19:1999;6795-6805.
64. Munro S., Thomas K.L., Abu Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
65. Munson A.E., Harris L.S., Friedman M.A., Dewey W.L., Carchman R.A. Antineoplastic activity of cannabinoids. J Natl Cancer Inst. 55:1975;597-602.
66. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S.H., Jin K., Greenberg D.A. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci. 19:1999;2987-2995.
67. Pertwee R.G. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Exp Opin Invest Drugs. 9:2000;1-19.
68. Piomelli D. The ligand that came from within. Trends Pharmacol Sci. 22:2001;17-19.
69. Piomelli D., Giuffrida A., Calignano A., Rodríguez de Fonseca F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci. 21:2000;218-224.
70. Pop E. Dexanabinol. Curr Opin Invest Drugs. 1:2000;493-503.
71. Porter A.C., Felder C.C. The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther. 90:2001;45-60.
72. Radin N.S. Killing cancer cells by poly-drug elevation of ceramide levels. A hypothesis whose time has come? Eur J Biochem. 268:2001;193-204.
73. Robbe D., Alonso G., Duchamp F., Bockaert J., Manzoni O. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci. 21:2001;109-116.
74. 1 cannabinoid receptor is coupled to the action of c-Jun N-terminal kinase. Mol Pharmacol. 58:2000;814-820.
75. 9-Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Lett. 458:1999;400-404.
76. 9-tetrahydrocannabinol. Life Sci. 60:1997;1709-1717.
77. 9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 436:1998;6-10.
78. 9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol. 54:1998;834-843.
79. 2 cannabinoid receptor. Cancer Res. 61:2001;5784-5789.
80. 1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein FAN. Mol Pharmacol. 59:2001;955-959.
81. Sarker K.P., Obara S., Nakata M., Kitajima I., Maruyama I. Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Lett. 472:2000;39-44.
82. Sastry P.S., Rao K.S. Apoptosis and the nervous system. J Neurochem. 74:2000;1-20.
83. Scallet A.C. Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals. Pharmacol Biochem Behav. 40:1991;671-676.
84. Scallet A.C., Uemure E., Andrews A., Ali S.F., McMillan D.E., Paule M.C., Brown R.M., Slikker W. Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC). Brain Res. 436:1987;193-198.
85. Schmelz E.M., Bushnev A.S., Dillehay D.L., Sullards M.C., Liotta D.C., Merrill A.H. Jr. Ceramide-β-D-glucuronide: synthesis, digestion, and suppression of early markers of colon carcinogenesis. Cancer Res. 59:1999;5768-5772.
86. Schwarz H., Blanco F.J., Lotz M. Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol. 55:1994;107-115.
87. Shen M., Thayer S.A. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol. 54:1998;459-462.
88. Shen M., Piser T.M., Seybold V.S., Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci. 16:1996;4322-4334.
89. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant. J Neuroimmunol. 72:1997;169-177.
90. Sinor A.D., Irvin S.M., Greenberg D.A. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett. 278:2000;157-160.
91. Skaper S.D., Buriani A., Dal Toso R., Petrelli L., Romanello S., Facci L., Leon A. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA. 93:1996;3984-3989.
92. Slipetz D.M., O'Neill G.P., Favreau L., Dufresne C., Gallant M., Gareau Y., Guay D., Labelle M., Metters K.M. Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol. 48:1995;352-361.
93. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
94. Szolcsanyi J. Anandamide and the question of its functional role for activation of capsaicin receptors. Trends Pharmacol Sci. 21:2000;203-204.
95. Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol. 78:1997;43-50.
96. Valk P.J.M., Hol S., Vankan Y., Ihle J.N., Askew D., Jenkins N.A., Gilbert D.J., Copeland N.G., de Both N.J., Löwenberg B., Delwel R. The genes encoding the peripheral cannabinoid receptor and α-L-fucosidase are located near a newly identified common virus integration site, Evi11. J Virol. 71:1997;6796-6804.
97. Valk P., Verbarkel S., Vankan Y., Hol S., Mancham S., Ploemacher R., Mayen A., Löwenberg B., Delwel R. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood. 90:1997;1448-1457.
98. Valk P.J., Vankan Y., Joosten M., Jenkins N.A., Copeland N.G., Löwenberg B., Delwel R. Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincides with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2. J Virol. 73:1999;3595-3602.
99. 9-tetrahydrocannabinol, the main active compound of marijuana, against ouabain-induced in vivo excitotoxicity. J Neurosci. 21:2001;6475-6479.
100. 9-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1. Eur J Biochem. 268:2001;531-535.
101. Venance L., Piomelli D., Glowinski J., Giaume C. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature. 376:1995;590-594.
102. Wartmann M., Campbell D., Subramanian A., Burstein S.H., Davis R.J. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett. 359:1995;133-136.
103. Wiesner D.A., Dawson G. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J Neurochem. 66:1996;1418-1425.
104. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 410:2001;588-592.
105. 9-Tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J Pharmacol Exp Ther. 286:1998;1103-1109.
106. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Högestätt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.